Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control study

Published:2017-10-18 Issue:3 Volume:14 Page:198-203
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Yang Fu Ou¹,Hsu Nicholas C.²,Moi Sin-Hua³,Lu Yin-Che⁴,Hsieh Chia-Ming⁵,Chang King-Jen⁶,Chen Dar-Ren⁷,Tu Chi-Wen⁸,Wang Hwei-Chung⁹,Hou Ming-Feng¹²¹⁰^ORCID

Affiliation:

1. Department of Surgery; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

2. Graduate Institute of Clinical Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

3. Breast Cancer Society of Taiwan; Taipei Taiwan

4. Department of Hematology-Oncology; Ditmanson Medical Foundation; Chia-Yi Christian Hospital; Chiayi Taiwan

5. Breast Center; Taiwan Adventist Hospital; Taipei Taiwan

6. Department of Surgery; National Taiwan University Hospital; Taipei Taiwan

7. Department of Surgery; Changhua Christian Hospital; Changhua Taiwan

8. Department of Surgery; Chiayi Christian Hospital; Chiayi Taiwan

9. Department of Surgery; China Medical University Hospital; Taichung Taiwan

10. Kaohsiung Municipal Hsiao-Kang Hospital; Kaohsiung Taiwan

Funder

TTY Biopharma, Taiwan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12771/fullpdf

Reference29 articles.

1. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer;Ahmann;Cancer Chemother Rep.,1974

2. A preliminary trial of doxorubicin in advanced breast cancer and other malignant disease;Cole;Br J Cancer.,1974

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet.,2005

4. Adjuvant chemotherapy in breast cancer: to use or not to use, the anthracyclines;Crozier;World J Clin Oncol.,2014

5. Long-term toxic effects of adjuvant chemotherapy in breast cancer;Azim;Ann Oncol.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer: A Prospective, Randomized, Multicenter, Phase II Study;Oncology Research and Treatment;2024-07-19

2. Review: Deep Learning-Based Survival Analysis of Omics and Clinicopathological Data;Inventions;2024-05-16

3. The effectiveness of liposomal doxorubicin hydrochloride in combination with cyclophosphan in the treatment of breast cancer in an experiment;Research and Practical Medicine Journal;2021-12-08

4. Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial;Current Oncology;2021-12-07

5. Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study;BMC Cancer;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3